"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".

PMR is a common inflammatory rheumatic disease. Although its clinical characteristics are fully recognized, no specific test for its diagnosis has been established to date. Several studies have described a wide variety of diseases that present with polymyalgic symptoms. A 18FDG-PET/CT scan could hel...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Patricia Moya-Alvarado, Alejandro Fernandez Leon, Maria Emilia Corica, Valle Camacho Marti, Diego Alfonso López-Mora, Ivan Castellví, Hèctor Corominas
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/bfffc924dd614a2eb92535b99a6b81c7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bfffc924dd614a2eb92535b99a6b81c7
record_format	dspace
spelling	oai:doaj.org-article:bfffc924dd614a2eb92535b99a6b81c72021-12-02T20:14:12Z"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".1932-620310.1371/journal.pone.0255131https://doaj.org/article/bfffc924dd614a2eb92535b99a6b81c72021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255131https://doaj.org/toc/1932-6203PMR is a common inflammatory rheumatic disease. Although its clinical characteristics are fully recognized, no specific test for its diagnosis has been established to date. Several studies have described a wide variety of diseases that present with polymyalgic symptoms. A 18FDG-PET/CT scan could help to deal with these differential diagnoses. The goal of our study is to describe the findings of the 18FDG-PET/CT scan in a cohort of PMR patients and to detail how the 18FDG-PET/CT scan improves accuracy when diagnosing other underlying conditions. This cross-sectional study enrolled patients with a diagnosis of PMR who underwent to a 18FDG-PET/CT scan to rule out other diagnosis. The 18FDG-PET/CT scan was performed either following clinical criteria at the onset of clinical symptoms or when the patient became PMR steroid resistant. Patients' demographic, clinical and analytical data at the moment of the 18FDG-PET/CT scan were recorded. The final diagnosis was confirmed according to clinical judgement. A total of 103 patients with PMR were included. In 49.51% of patients, the 18FDG-PET/CT scan was ordered to study resistance to steroid therapy. The final diagnoses of patients were PMR in 70.9% patients, large vessel vasculitis in 15.5%, neoplasms 4.8% and another diagnosis in the rest. The 18FDG-PET/CT scan is a very useful technique for the study of Polymyalgia Rheumatica, not only to help in the diagnostic process, but also due to its role in the identification of a variety of PMR-like patrons.Patricia Moya-AlvaradoAlejandro Fernandez LeonMaria Emilia CoricaValle Camacho MartiDiego Alfonso López-MoraIvan CastellvíHèctor CorominasPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0255131 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Patricia Moya-Alvarado Alejandro Fernandez Leon Maria Emilia Corica Valle Camacho Marti Diego Alfonso López-Mora Ivan Castellví Hèctor Corominas "The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
description	PMR is a common inflammatory rheumatic disease. Although its clinical characteristics are fully recognized, no specific test for its diagnosis has been established to date. Several studies have described a wide variety of diseases that present with polymyalgic symptoms. A 18FDG-PET/CT scan could help to deal with these differential diagnoses. The goal of our study is to describe the findings of the 18FDG-PET/CT scan in a cohort of PMR patients and to detail how the 18FDG-PET/CT scan improves accuracy when diagnosing other underlying conditions. This cross-sectional study enrolled patients with a diagnosis of PMR who underwent to a 18FDG-PET/CT scan to rule out other diagnosis. The 18FDG-PET/CT scan was performed either following clinical criteria at the onset of clinical symptoms or when the patient became PMR steroid resistant. Patients' demographic, clinical and analytical data at the moment of the 18FDG-PET/CT scan were recorded. The final diagnosis was confirmed according to clinical judgement. A total of 103 patients with PMR were included. In 49.51% of patients, the 18FDG-PET/CT scan was ordered to study resistance to steroid therapy. The final diagnoses of patients were PMR in 70.9% patients, large vessel vasculitis in 15.5%, neoplasms 4.8% and another diagnosis in the rest. The 18FDG-PET/CT scan is a very useful technique for the study of Polymyalgia Rheumatica, not only to help in the diagnostic process, but also due to its role in the identification of a variety of PMR-like patrons.
format	article
author	Patricia Moya-Alvarado Alejandro Fernandez Leon Maria Emilia Corica Valle Camacho Marti Diego Alfonso López-Mora Ivan Castellví Hèctor Corominas
author_facet	Patricia Moya-Alvarado Alejandro Fernandez Leon Maria Emilia Corica Valle Camacho Marti Diego Alfonso López-Mora Ivan Castellví Hèctor Corominas
author_sort	Patricia Moya-Alvarado
title	"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
title_short	"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
title_full	"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
title_fullStr	"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
title_full_unstemmed	"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".
title_sort	"the added value of 18f-fdg pet/ct in the assessment of onset and steroid resistant polimyalgia rheumatica".
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/bfffc924dd614a2eb92535b99a6b81c7
work_keys_str_mv	AT patriciamoyaalvarado theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica AT alejandrofernandezleon theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica AT mariaemiliacorica theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica AT vallecamachomarti theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica AT diegoalfonsolopezmora theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica AT ivancastellvi theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica AT hectorcorominas theaddedvalueof18ffdgpetctintheassessmentofonsetandsteroidresistantpolimyalgiarheumatica
_version_	1718374731851235328

"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica".

Ejemplares similares